ClinicalTrials.Veeva

Menu

EndometrioSis PRediction and Assessment of InflammaTion (ESPRIT)

Imperial College London logo

Imperial College London

Status

Completed

Conditions

Endometriosis

Treatments

Diagnostic Test: Diagnostic laparoscopy

Study type

Observational

Funder types

Other

Identifiers

NCT07114081
22/PR/0483

Details and patient eligibility

About

The goal of this observational study is to develop a non-invasive predictive algorithm for a diagnosis of endometriosis in a group of symptomatic women attending for their first laparoscopic surgical procedure for symptoms that are suspicious for pelvic endometriosis and to understand the role of peripheral markers of inflammation in enhancing this diagnosis.

The main questions it aims to answer are:

Can a non-invasive quantitative algorithm ('Endometriosis Diagnostic Index') accurately predict the presence or absence of pelvic endometriosis? Is the peripheral inflammatory environment (for example, presence of inflammatory cytokines and chemokine) different between people with and without endometriosis?

Enrollment

264 patients

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

• Consecutive female patients age 18-50 undergoing laparoscopy with the suspicion of endometriosis (as indicated by any recording in secondary care medical notes of endometriosis being a possible finding at laparoscopy; all those undergoing laparoscopy for sub-fertility (no conception after ≥6 months of trying, excluding confirmed male factor); or pelvic pain symptoms (dysmenorrhea; non-cyclical pelvic pain; dyspareunia; dyschezia) who is not otherwise excluded.

Exclusion criteria

  • previous surgically confirmed endometriosis;
  • postmenopausal status;
  • laparoscopy for acute indication (ectopic; tubo-ovarian abscess; adnexal torsion);
  • suspicion of malignancy;
  • the sole indication of tubal sterilisation;
  • the sole indication of myomectomy;
  • pregnant or breastfeeding;
  • significant medical co-morbidities including HIV and/or hepatitis B or C infection;
  • where gynaecology is not the primary team undertaking surgery;
  • unable to have transvaginal ultrasound (TVUSS);
  • declines to take part in the study;
  • patient unable to understand verbal or written information in English;
  • lack of capacity to consent at the point of recruitment;
  • known safeguarding issues.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems